دورية أكاديمية

Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

التفاصيل البيبلوغرافية
العنوان: Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.
المؤلفون: Omata, Masao, Kanda, Tatsuo, Yokosuka, Osamu, Crawford, Darrell, Al-Mahtab, Mamun, Wei, Lai, Ibrahim, Alaaeldin, Lau, George, Sharma, Barjesh, Hamid, Saeed, Chuang, Wan-Long, Dokmeci, A.
المصدر: Hepatology International; Oct2015, Vol. 9 Issue 4, p486-507, 22p
مستخلص: Estimated hepatitis C virus (HCV) infection rates in the general populations were 1.3, 0.9, 0.4-1.0, 14.7, 0.1-0.3, 0.9-1.9, 1.0-2.0, 5, 4.4-8.6 and 0.5-1.3 % in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. The main HCV genotypes (Gs) are G1, G3, G1b, G4, G1b, G3, G1b, G3, G1b and G2, and G1 in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. Of IL28B genotypes, favorable alleles are ~50 % in Australia and Turkey, but 60-70 % in most of the other Asian countries. Peginterferon plus ribavirin is available in all ten Asian Pasific countries. In addition, HCV NS3/4A protease inhibitors with peginterferon plus ribavirin are currently available in several countries. Clinical trials of interferon-free regimens for HCV are ongoing in most of the ten Asian Pacific countries. [ABSTRACT FROM AUTHOR]
Copyright of Hepatology International is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19360533
DOI:10.1007/s12072-015-9630-4